Headlines about ITUS Corporation (NASDAQ:ITUS) have been trending somewhat positive recently, according to Accern. The research group rates the sentiment of press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ITUS Corporation earned a media sentiment score of 0.15 on Accern’s scale. Accern also gave news headlines about the business services provider an impact score of 46.1970180196108 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Shares of ITUS Corporation (NASDAQ:ITUS) traded up $0.12 on Tuesday, reaching $2.53. 323,900 shares of the company’s stock traded hands, compared to its average volume of 759,198. ITUS Corporation has a 52 week low of $0.60 and a 52 week high of $6.25.
WARNING: This story was originally published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.chaffeybreeze.com/2017/11/14/itus-corporation-itus-receiving-somewhat-favorable-media-coverage-report-shows.html.
About ITUS Corporation
ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient’s immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream.
Receive News & Ratings for ITUS Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITUS Corporation and related companies with MarketBeat.com's FREE daily email newsletter.